Which intravenous corticosteroid should be used for widespread bullous pemphigoid?

Intravenous Methylprednisolone for Widespread Bullous Pemphigoid

For widespread bullous pemphigoid requiring intravenous corticosteroids, use intravenous methylprednisolone at either 1 g daily or 15 mg/kg/day for 3 days, followed by oral prednisone 30-40 mg daily. However, this approach carries significant mortality risk and should be reserved only for the most severe cases that have failed standard oral corticosteroid therapy 1.

Critical Context: IV Steroids Are NOT First-Line

Before considering IV corticosteroids, you must understand that oral corticosteroids or topical clobetasol propionate are the recommended first-line treatments for widespread BP, not intravenous therapy 2, 1, 3. The evidence strongly favors starting with:

• Oral prednisone 0.5-0.75 mg/kg/day for extensive disease 2, 3
• Topical clobetasol propionate 30-40 g/day for extensive disease (superior outcomes with lower mortality) 4, 5

When IV Methylprednisolone May Be Considered

IV methylprednisolone should only be used in:

• Severe widespread BP that has failed to respond to standard oral corticosteroid doses (0.75-1.0 mg/kg/day prednisone)
• Patients requiring rapid disease control in life-threatening situations

Dosing Protocol

The specific regimen studied 1:

• 1 g methylprednisolone IV daily for 3 days, OR
• 15 mg/kg methylprednisolone IV daily for 3 days
• Followed by oral prednisone 30-40 mg daily

Major Safety Concerns

This approach has documented high mortality risk. In the study of 8 patients receiving IV methylprednisolone 1:

• 1 patient died within 1 week
• 3 additional patients died between 1-4 months post-treatment
• Causes of death: cardiac arrest, infection, congestive cardiac failure
• All patients had significant medical comorbidities
• Disease recurred within 2 weeks despite oral prednisone continuation

The evidence shows that increasing corticosteroid doses beyond 0.75-1.0 mg/kg/day confers little additional benefit but significantly increases toxicity 1.

Why This Matters for Mortality

The guidelines explicitly state that systemic corticosteroids at doses of 1 mg/kg/day are associated with higher mortality compared to topical clobetasol propionate 2. A 2024 study confirmed that systemic corticosteroids increase all-time risk of death (HR 1.43), MACE (HR 1.33), and infections (HR 1.33) compared to topical treatment 5.

Practical Algorithm

1. First-line: Oral prednisone 0.5-0.75 mg/kg/day OR topical clobetasol propionate 30-40 g/day
2. If inadequate response in 1-3 weeks: Increase oral prednisone to 0.75 mg/kg/day (if started lower) 2
3. If still inadequate: Add immunosuppressive agent (azathioprine, mycophenolate mofetil, or methotrexate) rather than increasing corticosteroid dose 3
4. Only if truly refractory and life-threatening: Consider IV methylprednisolone as described above, with full informed consent about mortality risks

Common Pitfall

Do not reflexively use IV corticosteroids for "widespread" disease. The term "widespread" or "extensive" BP is an indication for treatment intensification, but this means oral prednisone 0.5-0.75 mg/kg/day or topical clobetasol 30-40 g/day, NOT intravenous therapy 2, 1, 3. IV methylprednisolone is reserved for the rare patient who fails these standard approaches and has truly refractory, life-threatening disease.